☆ 4.7 Article

Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma

BIOMEDICINE & PHARMACOTHERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma

Alexandra Lahtinen et al.

Summary: Ovarian HGSC is often diagnosed at an advanced stage, with genetically diverse clones existing prior to treatment. This study analyzed whole-genome sequencing data from 510 samples of 148 HGSC patients, revealing three evolutionary states with distinct genomic features, pathways, and phenotypes, which showed significant association with treatment response. Pathway analysis suggested two potential evolutionary trajectories, and experiments with tumor organoids supported targeted therapy for tumors with enriched PI3K/AKT pathway. Heterogeneity analysis indicated more unique clones in samples from the site of origin compared to metastatic tumors or ascites. These findings highlight the importance of integrative tumor evolution analysis for identifying patient subtypes.

CANCER CELL (2023)

添加到收藏夹

Review Oncology

Current and Future Clinical Applications of ctDNA in Immuno-Oncology

Julia-Christina Stadler et al.

Summary: Testing peripheral blood for circulating tumor DNA (ctDNA) offers a minimally invasive opportunity to diagnose, characterize, and monitor the disease in individual cancer patients. ctDNA can serve as a predictive biomarker for immune checkpoint inhibitor therapy and can help identify responders to the treatment.

CANCER RESEARCH (2022)

添加到收藏夹

Review Oncology

Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division

Cheng-Zhong Zhang et al.

Summary: This review summarizes the progress in the analysis of cancer genomes, providing significant insights into the origin, mechanism, and evolutionary dynamics of cancer genome complexity through computational analysis and experimental recapitulation. It particularly focuses on the relative contributions of chromosome fragmentation and DNA replication errors to complex chromosomal alterations.

ANNUAL REVIEW OF CANCER BIOLOGY (2022)

添加到收藏夹

Review Endocrinology & Metabolism

The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination

Sabrina J. Ritch et al.

Summary: Epithelial ovarian cancer is the deadliest gynecological disease, commonly diagnosed at late stages with metastasis. Understanding the unique microenvironments that promote EOC dissemination is crucial in improving patient outcomes.

FRONTIERS IN ENDOCRINOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Signatures of copy number alterations in human cancer

Christopher D. Steele et al.

Summary: Gains and losses of DNA are prevalent in cancer and contribute to cancer initiation, progression, and therapeutic resistance. A study identified 21 copy number signatures that explain 97% of the sample's copy number patterns.

NATURE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer

Filipe Correia Martins et al.

Summary: Identification of clonal somatic copy number alterations in cancer genes can guide precision medicine for high-grade serous ovarian carcinoma.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Biochemical Research Methods

A practical guide to cancer subclonal reconstruction from DNA sequencing

Maxime Tarabichi et al.

Summary: The Perspective reviews computational methods for subclonal reconstruction in cancer evolution studies, outlining complex approaches and best practices for analysis. It provides insight into clonality and mutational processes, identifying underlying assumptions and uncertainties in each step. This guide serves as a pragmatic resource for the growing user community of subclonal reconstruction methods.

NATURE METHODS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Cell-free DNA concentration and fragment size as a biomarker for prostate cancer

Emmalyn Chen et al.

Summary: This study investigated the potential of using cfDNA as a biomarker for detecting more advanced and aggressive prostate cancer. It found that elevated cfDNA concentration was associated with metastatic castration-resistant prostate cancer, while decreased fragment size was linked to a higher risk of localized disease. However, the sensitivity and specificity of cfDNA as a diagnostic marker for distinguishing between healthy individuals and those with localized prostate cancer remain imperfect.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Pathology

Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics

Paul Roepman et al.

Summary: Whole genome sequencing (WGS) in cancer diagnosis demonstrates high sensitivity and precision, reliably detecting various mutation types and serving as the most comprehensive genetic testing method.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden

Guanhua Zhu et al.

Summary: Profiling of ctDNA using local tissue-specific cfDNA degradation patterns accurately estimates ctDNA burden, while predictive power of 6 specific regulatory regions is strong. A quantitative model and compact targeted sequencing enable low-cost tracking of ctDNA dynamics and disease progression across colorectal and breast cancer patients.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Oncology

Increased detection of circulating tumor DNA by short fragment enrichment

Yang Liu et al.

Summary: In this study, a new method was developed using a large proportion of magnetic beads to enrich short cfDNA fragments, which effectively improved the sensitivity of ctDNA detection, especially in low variant allele frequency samples. The method showed promising results in both commercial cfDNA references and real-world clinical samples.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

添加到收藏夹

Article Oncology

Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

Lara Paracchini et al.

Summary: TF in plasma serves as an independent prognostic marker for disease progression and relapse in HGS-EOC patients. After platinum-based treatment, ctDNA analysis shows changes in genomic amplification patterns, with serially collected ctDNA samples' TF outperforming CA-125 in predicting disease progression.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Review Oncology

Genetic and non-genetic clonal diversity in cancer evolution

James R. M. Black et al.

Summary: This article discusses the importance of functional and non-functional intra-tumour heterogeneity (ITH) in cancer evolution. It emphasizes the need to consider genetic and non-genetic factors in tumor evolution, and highlights the role of systems-biology analytical approaches in understanding the functional ITH. Ultimately, deepening our understanding of tumour evolution through functional ITH will lead to the development of novel therapies and improved outcomes for patients.

NATURE REVIEWS CANCER (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living

Ellen Heitzer et al.

TRENDS IN MOLECULAR MEDICINE (2020)

添加到收藏夹

Article

Circulating tumor DNA analysis in the era of precision oncology

Rabih Said et al.

Oncotarget (2020)

添加到收藏夹

Article Biology

CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications

Sebastia Franch-Exposito et al.

ELIFE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer

Silvia R. Vitale et al.

BIOMOLECULES (2020)

添加到收藏夹

Review Health Care Sciences & Services

Impact of tumor heterogeneity and tissue sampling for genetic mutation testing: a systematic review and post hoc analysis

Stephanie L. Swift et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)

添加到收藏夹

Article Genetics & Heredity

Subclonal reconstruction of tumors by using machine learning and population genetics

Giulio Caravagna et al.

NATURE GENETICS (2020)

添加到收藏夹

Review Oncology

Circulating tumor DNA and liquid biopsy in oncology

David W. Cescon et al.

NATURE CANCER (2020)

添加到收藏夹

Article Multidisciplinary Sciences

The ENCODE Blacklist: Identification of Problematic Regions of the Genome

Haley M. Amemiya et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells

Yue Han et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

添加到收藏夹

Article Genetics & Heredity

Copy number variation is highly correlated with differential gene expression: a pan-cancer study

Xin Shao et al.

BMC MEDICAL GENETICS (2019)

添加到收藏夹

Review Genetics & Heredity

Current and future perspectives of liquid biopsies in genomics-driven oncology

Ellen Heitzer et al.

NATURE REVIEWS GENETICS (2019)

添加到收藏夹

Article Oncology

RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer

Daniel Nava Rodrigues et al.

CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Oncology

Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer

Jaana Oikkonen et al.

JCO PRECISION ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma

Yong-Man Kim et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)

添加到收藏夹

Article Genetics & Heredity

Copy number signatures and mutational processes in ovarian carcinoma

Geoff Macintyre et al.

NATURE GENETICS (2018)

添加到收藏夹

Article Genetics & Heredity

TarSeqQC: Quality control on targeted sequencing experiments in R

Gabriela A. Merino et al.

HUMAN MUTATION (2017)

添加到收藏夹

Article Oncology

Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer

M. Jamal-Hanjani et al.

ANNALS OF ONCOLOGY (2016)

添加到收藏夹

Article Biochemical Research Methods

Integrated genome browser: visual analytics platform for genomics

Nowlan H. Freese et al.

BIOINFORMATICS (2016)

添加到收藏夹

Article Oncology

Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations

David M. Roy et al.

CANCER CELL (2016)

添加到收藏夹

Article Genetics & Heredity

Punctuated copy number evolution and clonal stasis in triple-negative breast cancer

Ruli Gao et al.

NATURE GENETICS (2016)

添加到收藏夹

Article Genetics & Heredity

Fragment Length of Circulating Tumor DNA

Hunter R. Underhill et al.

PLOS GENETICS (2016)

添加到收藏夹

Article Medicine, General & Internal

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

Christine A. Parkinson et al.

PLOS MEDICINE (2016)

添加到收藏夹

Article Mathematical & Computational Biology

PureCN: copy number calling and SNV classification using targeted short read sequencing

Markus Riester et al.

SOURCE CODE FOR BIOLOGY AND MEDICINE (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants

Aziz Belkadi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

添加到收藏夹

Article Oncology

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

L. De Mattos-Arruda et al.

ANNALS OF ONCOLOGY (2014)

添加到收藏夹

Review Oncology

Cancer heterogeneity: implications for targeted therapeutics

R. Fisher et al.

BRITISH JOURNAL OF CANCER (2013)

添加到收藏夹

Review Biochemistry & Molecular Biology

Gene Copy-Number Alterations: A Cost-Benefit Analysis

Yun-Chi Tang et al.

CELL (2013)

添加到收藏夹

Article Genetics & Heredity

Pan-cancer patterns of somatic copy number alteration

Travis I. Zack et al.

NATURE GENETICS (2013)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Copynumber: Efficient algorithms for single- and multi-track copy number segmentation

Gro Nilsen et al.

BMC GENOMICS (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Integrated genomic analyses of ovarian carcinoma

D. Bell et al.

NATURE (2011)

添加到收藏夹

Article Biotechnology & Applied Microbiology

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

Craig H. Mermel et al.

GENOME BIOLOGY (2011)

添加到收藏夹

Article Oncology

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

Ashour Ahmed Ahmed et al.

JOURNAL OF PATHOLOGY (2010)

添加到收藏夹

Article Genetics & Heredity

Segmental copy number variation shapes tissue transcriptomes

Charlotte N. Henrichsen et al.

NATURE GENETICS (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.